Today at Medtrade Spring in Las Vegas, Nevada (March 27-29), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of DreamWear Full face, the third mask option available for its award-winning DreamWear mask system. Philips Respironics, the number one choice brand of U.S. sleep physicians for continuous positive airway pressure (CPAP) and masks, used the company’s proprietary design tools to analyze facial data from thousands of 3D scans to create a design that prevents red marks, discomfort, and irritation on the nose bridge.
According to a recent global Philips survey , sleep apnea patients say the top challenges to using CPAP therapy are that the mask can leave red marks on the face (40 percent) and the hose gets in the way (40 percent). Additionally, 38 percent of respondents say traditional masks limit their range of motion, and three in five respondents (63 percent) said they noticed they had a tendency to breathe through their mouth before being tested for sleep apnea. Recognizing the challenges sleep apnea patients face when choosing sleep therapy, Philips aims to help patients experience the most comfortable night’s sleep possible.
“We’ve found that patients’ acceptance and adherence to PAP therapy for sleep apnea are very much rooted in selecting a properly-fitting, effective and comfortable mask,” said Dr. Teofilo Lee-Chiong, chief medical liaison at Philips. “Our recent survey highlights the challenges that therapy users are experiencing all over the world and validates the work Philips has been doing to help them to improve their quality of life.”
The new DreamWear Full face mask was designed to expand on current Dream Family offerings, with the goal of providing a better option for sleep apnea patients who breathe through their mouths. Philips DreamWear Full face features include:
• Comfort: To help combat the challenges that come with wearing a CPAP mask, Philips designed the new DreamWear Full face mask that patients say comes closest to feeling like there’s nothing on the face. Users rate the DreamWear Full face mask more comfortable and less intimidating than their prescribed mask . Its innovative design helps to prevent red marks, discomfort or irritation on the nose bridge as the cushion is designed to sit under the nose, not on it.
• Convenience: The new full face cushion is one of three available for the DreamWear mask system, which directs airflow through the frame and removes the hose from the front of the face, giving patients more freedom to sleep comfortably in any position they desire. The offering also provides an option for patients when they can no longer breathe through their nose from allergies or a cold. Additionally, the third cushion option provides cash-pay opportunities for DMEs and additional mask options for patients to help offer them the best chance of long-term therapy success.
• Quality: The DreamWear Full face mask was built with a thorough understanding of facial geometries and a suite of proprietary design tools and processes to provide patients with clinically proven fit, comfort and seal.
Philips at Medtrade Spring
The DreamWear Full face cushion is the latest addition to Philips’ Dream Family of sleep apnea products focused on connecting and supporting the patient, clinician and homecare provider to enhance patient care and quality of life. For more information, visit Philips at booth #613 at Medtrade Spring, March 27-29, 2018 at the Mandalay Bay Convention Center in Las Vegas. Other Philips products on display at the show highlight the company’s innovation in sleep therapy and respiratory care.
For more on Philips’ advanced solutions for sleep and respiratory care, follow @PhilipsResp or www.philips.com.
 Survey conducted online by Regina Corso Consulting on behalf of Philips from January 15-22, among 2,000 adults in the U.S., Australia, France, Germany and Canada, all of who have sleep apnea and use a CPAP machine. For complete survey methodology, please contact Meredith Amoroso at email@example.com.
 Data analysis of Aug 2017 Patient Preference trial where n = 85 and prescribed masks include Resmed Airfit FlO and F20, Respironics Amara View and F&P Simplus; based on 10 days of use.